BioCatalyst

Amlitelimab — catalyst calendar

2 verified catalyst event(s) referencing Amlitelimab, each linked to its official source. Verified as of 2026-06-22.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-06-29
in 7d
ESTIMATED
 READOUT
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Su
Phase 3 · Dermatitis Atopic
 SNY Sanofi Amlitelimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
2026-09-29
in 3mo
ESTIMATED
 READOUT
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Pa
Phase 2 · Asthma
 SNY Sanofi Amlitelimab ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.